|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 258.00 USD | -0.81% |
|
-3.52% | -35.12% |
| Market Cap | 34.52B 29.71B 27.97B 25.49B 47.69B 3,285B 47.88B 332B 128B 1,674B 130B 127B 5,302B | P/E 2026 * |
39.1x | P/E 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 31.77B 27.33B 25.74B 23.45B 43.88B 3,023B 44.05B 305B 118B 1,540B 119B 117B 4,879B | EV / Sales 2026 * |
5.79x | EV / Sales 2027 * | 4.34x |
| Free-Float |
99.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALNY | Delayed | |
CBOE
| ALNY | Real-time | |
|
Tradegate
| DUL | Real-time | |
|
Berne S.E.
| DUL | End-of-day quote | |
|
London S.E.
| 0HD2 | Delayed | |
|
Boerse Muenchen
| DUL | Real-time | |
|
Mexican S.E.
| ALNY * | End-of-day quote | |
|
Börse Stuttgart
| DUL | Delayed | |
|
Deutsche Boerse AG
| DUL | Delayed | |
|
Xetra
| DUL | End-of-day quote | |
|
Borsa Italiana
| 1ALNY | End-of-day quote | |
|
Wiener Boerse
| End-of-day quote |
Last Transcript : Alnylam Pharmaceuticals, Inc.
| 1 day | -0.81% | ||
| 1 week | -3.52% | ||
| Current month | +7.19% | ||
| 1 month | +17.70% | ||
| 3 months | -13.33% | ||
| 6 months | -20.27% | ||
| Current year | -35.12% |
| 1 week | 253.28 |  | 272.08 |
| 1 month | 216.5 | | 272.08 |
| Current year | 197.81 | | 427.05 |
| 1 year | 197.81 | | 495.55 |
| 3 years | 141.98 | | 495.55 |
| 5 years | 117.58 | | 495.55 |
| 10 years | 31.38 | | 495.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2021-12-31 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 58 | 2019-08-12 |
| Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 80 | 2012-04-22 |
Amy Schulman
CHM | Chairman | 65 | 2023-01-04 |
David Pyott
BRD | Director/Board Member | 72 | 2015-12-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/1/26 | Exercice | Director | 11,490 | 0.0086% | ||
| 6/1/26 | Free | Director | 4,393 | 0.0033% | ||
| 5/20/26 | Free | Director | 2,112 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | -3.52% | -46.49% | +28.08% | 34.52B | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 644B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 443B | |
| -0.80% | -0.43% | +28.92% | +35.45% | 343B | |
| -0.13% | -14.97% | +9.41% | +26.71% | 262B | |
| -1.90% | -2.72% | -2.72% | +7.41% | 245B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 212B | |
| -1.06% | -4.23% | -14.70% | -57.36% | 199B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 181B | |
| Average | -0.59% | -3.41% | +15.99% | +40.92% | 356.42B | |
| Weighted average by Cap. | -0.42% | -3.80% | +31.27% | +56.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.48B 4.72B 4.44B 4.05B 7.57B 522B 7.6B 52.66B 20.35B 266B 20.59B 20.14B 842B | 6.93B 5.96B 5.61B 5.11B 9.57B 659B 9.61B 66.53B 25.71B 336B 26.02B 25.45B 1,064B |
| Net income | 908M 782M 736M 670M 1.25B 86.42B 1.26B 8.72B 3.37B 44.03B 3.41B 3.34B 139B | 1.29B 1.11B 1.05B 955M 1.79B 123B 1.79B 12.42B 4.8B 62.68B 4.85B 4.75B 199B |
| Net Debt | -2.76B -2.37B -2.23B -2.04B -3.81B -262B -3.82B -26.47B -10.23B -134B -10.35B -10.13B -423B | -4.44B -3.82B -3.59B -3.27B -6.13B -422B -6.15B -42.59B -16.46B -215B -16.66B -16.29B -681B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | US$258.00 | -0.81% | 1,426,414 |
| 26-09-08 | US$260.10 | -2.26% | 2,008,633 |
| 26-09-04 | US$266.11 | +0.61% | 1,431,221 |
| 26-09-03 | US$264.50 | -1.08% | 1,710,078 |
| 26-09-02 | US$267.40 | +8.65% | 3,286,329 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALNY Stock
Select your edition
All financial news and data tailored to specific country editions
